NCT04266132

Brief Summary

Regional analgesia for inguinal hernia repair in children has attracted increasing interest and different techniques like Caudal block, lumbar epidural block, wound infiltration, Ilio-inguinal nerve block and paravertebral block have been used with varying success. Ilio-inguinal nerve blockade has been widely used in this context but the duration of the block is also limited to the early postoperative period. Paravertebral blockade has been shown to produce long lasting postoperative analgesia when used in combination with general anaesthesia in paediatric herniorrhaphy . Ultrasound-guided retrolaminar block is one of the newer and technically simpler alternatives to the traditional PV block . The aim of this study is to test the efficacy and safety of ultrasound guided retrolaminar block(RLB) as an analgesic technique in surgery of pediatric inguinal hernia in comparison with with ilioinguinal nerve block(INB). It is hypothesized that RLB block will provide longer duration of postoperative analgesia than INB with few side effects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 12, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

May 17, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2020

Completed
Last Updated

May 19, 2020

Status Verified

May 1, 2020

Enrollment Period

5 months

First QC Date

February 10, 2020

Last Update Submit

May 17, 2020

Conditions

Keywords

Retrolaminar blockIlioinguinal nerve block

Outcome Measures

Primary Outcomes (1)

  • First analgesic request

    The time of the first analgesic request will be recorded.

    [Time Frame: Up to 24 hours after the procedure]

Secondary Outcomes (5)

  • Improvement in pain score

    [Time Frame: Up to 24 hours after the procedure]

  • Levels of parental satisfaction after surgery

    .[Time Frame: Up to 24hours after the procedure]

  • Incidence of adverse effects

    [Time Frame: Up to 24 hours after the procedure]

  • Changes in heart rate

    [Time Frame: Up to 24 hours after the procedure]

  • Changes in systolic blood pressure

    [Time Frame: Up to 24 hours after the procedure]

Study Arms (2)

Retrolamianar block (RLB)

ACTIVE COMPARATOR

General anaesthesia will be induced.Ultrasound-guided RLB will be performed under strict aseptic precautions with patient in the lateral position.The anesthetic solution will be injected.

Procedure: General anaesthesiaProcedure: Ultrasound-guided RLBDrug: Bupivacaine

Ilioinguinal nerve block (INB)

ACTIVE COMPARATOR

General anaesthesia will be induced. Ultrasound-guided INB will be performed under strict aseptic precautions with patient in the supine position.The anesthetic solution will be injected.

Procedure: General anaesthesiaProcedure: Ultrasound-guided INBDrug: Bupivacaine

Interventions

General anaesthesia will be induced with 8% sevoflurane in oxygen and maintained with 1 MAC sevoflurane via a laryngeal mask.

Ilioinguinal nerve block (INB)Retrolamianar block (RLB)

The suggested ultrasound transducer orientation is sagittal paramedian (cephalacaudad direction). We begin our ultrasound scanning in a paramedian sagittal plane by finding desired level (T12- L1).The transverse process view, the costotransverse ligament can be visualized above the paravertebral space. Continuing to scan from lateral to medial, the vertebral laminae come into view.

Retrolamianar block (RLB)

A high-frequency probe is placed medial to the anterior superior iliac spine with the axis facing the umbilicus. A needle is inserted toward the ilioinguinal nerve as it runs between the transversus abdominis and internal oblique.

Ilioinguinal nerve block (INB)

0.3 ml.kg of 0.25% bupivacaine will be injected under visualization.

Ilioinguinal nerve block (INB)Retrolamianar block (RLB)

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • American Society of Anesthesiologists (ASA) status: 1 or 2 .
  • Unilateral inguinal hernia

You may not qualify if:

  • spinal abnormality
  • bilateral inguinal hernia repair
  • Bleeding or coagulation diathesis.
  • History of known sensitivity to the used anesthetics.
  • Parental refusal of consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura university children hospital

Al Mansurah, Egypt

RECRUITING

MeSH Terms

Conditions

Hernia, Inguinal

Interventions

Anesthesia, GeneralBupivacaine

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and AnalgesiaAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Mahmoud M Alseoudy, MD

    Faculty of Medicine, Mansoura University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mahmoud M Alseoudy, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double (Participant, Outcomes Assessor)The study subjects and the resident assessing the outcomes will be blinded to the study group. A single investigator will assess the patients for eligibility, obtain written informed consent, open the sealed opaque envelopes containing group allocation, perform the block, and administer bupivacaine solution.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, double blind study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of anesthesia, ICU & pain management; Faculty of Medicine

Study Record Dates

First Submitted

February 10, 2020

First Posted

February 12, 2020

Study Start

May 17, 2020

Primary Completion

October 15, 2020

Study Completion

November 20, 2020

Last Updated

May 19, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations